ArticleMedicine2025
Immediate analgesic effect of cervical localized rotation manipulation combined with cervical Huatuo-Jiaji electroacupuncture on cervicogenic headache.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to evaluate the immediate analgesic effect and safety of cervical localized rotation manipulation (CLRM) combined with cervical Huatuo-Jiaji electroacupuncture (CHJE) on cervicogenic headache (CEH) in a retrospective controlled study. A total of 300 patients with CEH who visited the pain and rehabilitation departments of a hospital from July 2024 to March 2025 were included and assigned to 3 groups according to their received treatments: CLRM, CHJE, and combined CLRM + CHJE (100 cases each). Primary outcomes included headache intensity (visual analog scale, VAS), pressure pain threshold, and somatosensory evoked potential-N13 latency. Secondary measures were cervical range of motion, serum β-endorphin and 5-hydroxytryptamine levels, headache frequency and duration, and adverse events. All groups showed significant improvement immediately after treatment, while the combined CLRM + CHJE group exhibited greater reductions in VAS scores, higher pressure pain threshold, and shorter somatosensory evoked potential-N13 latency compared with single interventions. The immediate analgesic response rate (≥50% VAS reduction) was highest in the combined group (71%). The combined therapy also improved cervical mobility, elevated serum β-endorphin and 5-hydroxytryptamine levels, and reduced associated symptoms. Only mild, self-limited adverse events were observed, with no serious complications reported. This retrospective controlled study suggests that CLRM combined with CHJE may provide superior immediate pain relief and functional improvement for patients with CEH compared with either treatment alone. The combined protocol appears to be safe, rapid in onset, and well tolerated. However, these findings reflect only short-term outcomes and should be interpreted cautiously until confirmed by prospective studies with long-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.